Does oxidative status affect serum sclerostin levels in patients with type 2 diabetes mellitus?
Introduction: Sclerostin is a glycoprotein known as a negative regulator of bone formation, predominantly expressed by mature  osteocytes. There is no causative evidence information on the role of sclerostin in the pathogenesis of type 2 diabetes mellitus (T2DM) in humans. ...
| Published in: | Folia Medica |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2023-02-01
|
| Subjects: | |
| Online Access: | https://foliamedica.bg/article/72953/download/pdf/ |